Granules India Ltd is in Breakout from a long term channel
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。